ArticleFrontiers in immunology2024

First-line treatments for extensive-stage small-cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a China-based cost-effectiveness analysis.

Lidan Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.